1. Home
  2. MATX vs APGE Comparison

MATX vs APGE Comparison

Compare MATX & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matson Inc.

MATX

Matson Inc.

HOLD

Current Price

$177.83

Market Cap

5.4B

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$86.56

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATX
APGE
Founded
1882
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.7B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
MATX
APGE
Price
$177.83
$86.56
Analyst Decision
Buy
Strong Buy
Analyst Count
5
13
Target Price
$150.00
$109.67
AVG Volume (30 Days)
188.1K
616.5K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
0.84%
N/A
EPS Growth
N/A
N/A
EPS
13.81
N/A
Revenue
$3,344,500,000.00
N/A
Revenue This Year
$4.65
N/A
Revenue Next Year
$4.31
N/A
P/E Ratio
$12.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$86.97
$34.34
52 Week High
$180.21
$95.32

Technical Indicators

Market Signals
Indicator
MATX
APGE
Relative Strength Index (RSI) 64.88 55.37
Support Level $155.21 $73.06
Resistance Level $178.22 $95.32
Average True Range (ATR) 4.63 3.61
MACD -0.02 -0.67
Stochastic Oscillator 77.16 36.11

Price Performance

Historical Comparison
MATX
APGE

About MATX Matson Inc.

Matson Inc is engaged in providing ocean transportation and logistics services. The company has two reportable business segments: Ocean Transportation and Logistics. The Ocean Transportation segment provides ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, California, Okinawa, and different islands in the South Pacific. The Logistics segment offers long-haul and regional highway trucking services, warehousing and distribution services, supply chain management, and freight forwarding services. The firm generates the majority of its revenue from the Ocean Transportation segment.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: